| 영문 | carcinoma in situ | 한글 | 상피내암종 |
|---|---|---|---|
| 설명 | 신체의 내부나 외부를 쌓고 있는 조직을 상피라고 한다. 이 상피의 아래에는 대개 상피를 지지하고 있는 조직의 위에 존재한다. 그리고 이 지지조직과 상피 사이에는 기저막이라는 막이 있어서 상피와 지지조직을 구분해 준다. 암종(carcinoma)란 상피의 세포가 악성 변화를 하여 생기는 암을 말한다. 제자리암종이란 암종의 한 종류로 암종이 기저막을 벗어나지 못하고 상피내 즉, 제자리에 머물러 있는 경우를 말한다. |
||
| aud-vis | audiovisual |
|---|---|
| qv | as much as you desire [Lat. quantum vis]; which see [Lat. quod vide] |
| VIS | vaginal irrigation smear; venous insufficiency syndrome; vertebral irritation syndrome; visible; vis... |
| vis | vision, visual |
| CIS | Carcinoma In Situ |
| UV/VIS | Ultraviolet, visible |
|---|---|
| ACIS | 3/adenocarcinoma in situ |
| AIS | Adeno-carcinoma in situ |
| CIS | Carcinoma in Situ |
| CISS | Chromosomal in situ suppression |
| vis | 1. Force; power. 2. Physical force. Moral power. <physiology> Principle of vis viva, living force; the force of a body moving against resistance, or doing work, in distinction from vis mortua, or dead force; the kinetic energy of a moving body; the capacity of a moving body to do work by reason of its being in motion. See Kinetic energy, in the Note under Energy. The term vis viva is not usually understood to include that part of the kinetic energy of the body which is due to the vibrations of its molecules. Source: Websters Dictionary (01 Mar 1998) |
|---|---|
| vis a fronte | A force acting from in front; an obstructive, restraining, or impeding force. (05 Mar 2000) |
| vis a tergo | A force acting from behind; a pushing or accelerating force. (05 Mar 2000) |
| vis conservatrix | The inherent power in the organism resisting the effects of injury. (05 Mar 2000) |
| vis vitae | <biology> The doctrine that all the functions of a living organism are due to an unknown vital principle distinct from all chemical and physical forces. Source: Websters Dictionary (01 Mar 1998) |
| quantum vis | See: q.v.. Origin: L. However much you wish (05 Mar 2000) |
| adenocarcinoma in situ | A noninvasive abnormal proliferation of glands believed to precede the appearance of invasive adenocarcinoma; reported in the endometrium, large intestine, cervix, and other sites. (05 Mar 2000) |
| carcinoma in situ | Cancer that involves only the cells in which it began and has not spread to other tissues. Lobular carcinoma in situ is found in the lobules of the breast. Ductal carcinoma in situ (also called intraductal carcinoma) arises in the ducts. (16 Dec 1997) |
| malignant melanoma in situ | A melanoma limited to the epidermis and composed of nests of atypical melanocytes and scattered single cells extending into the upper epidermis; local excision is curative although the lesion, if untreated, may soon invade the dermis. Malignant lentigo may be considered a slowly progressive type of malignant melanoma in situ. (05 Mar 2000) |
| ductal carcinoma in situ | <oncology, tumour> A cancer inside the ducts of breast that has not grown through the wall of the duct into the surrounding tissues. Sometimes referred to as a precancer. Good prognosis is involved with in situ cancers. (09 Oct 1997) |
| in situ | In the natural or normal place, confined to the site of origin without invasion of neighbouring tissues. (18 Nov 1997) |
| in situ hybridisation | <molecular biology, technique> Use of a DNA or RNA probe todetect the presence of the complementaryDNA sequence in cloned bacterial or cultured eukaryotic cells.Also used for locating geneson chromosomes. The process is: Prepare microscope slide with cells in metaphase of mitosis, Treat slide with a weak base. Thus denaturing the DNA. Pour radioactively labelled probe onto the slide. Expose slide to photographic emulsion for a few days or weeks. Develop emulsion. (13 Oct 1997) |
| in situ hybridization | <molecular biology> The use of a DNA or RNA probe to detect the complementary DNA sequence. (12 Dec 1998) |
| in situ nucleic acid hybridization | <molecular biology> The use of a DNA or RNA probe to detect the complementary DNA sequence. (12 Dec 1998) |
| fluorescence in situ hybridization | <molecular biology, technique> A type of in situ hybridization in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. Acronym: FISH (25 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|